Discovery of compound may open new road to diabetes treatment

The discovery of an inhibitor of the Insulin Degrading Enzyme (IDE), a protein responsible for the susceptibility of diabetes because it destroys insulin in the body, may lead to new treatment approaches for diabetes, researchers say. More than 20 million people live with type II diabetes in the United States, a disease in which the body cannot make sufficient amounts of the hormone insulin.